- Home
- REKR vs RAPT Comparison
REKR vs RAPT Comparison
Compare REKR & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- RAPT
- Stock Information
- Founded
- REKR 2017
- RAPT 2015
- Country
- REKR United States
- RAPT United States
- Employees
- REKR N/A
- RAPT N/A
- Industry
- REKR Telecommunications Equipment
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- REKR Telecommunications
- RAPT Health Care
- Exchange
- REKR Nasdaq
- RAPT Nasdaq
- Market Cap
- REKR 115.1M
- RAPT 117.5M
- IPO Year
- REKR N/A
- RAPT 2019
- Fundamental
- Price
- REKR $0.99
- RAPT $0.75
- Analyst Decision
- REKR
- RAPT Hold
- Analyst Count
- REKR 0
- RAPT 7
- Target Price
- REKR N/A
- RAPT $5.00
- AVG Volume (30 Days)
- REKR 3.0M
- RAPT 826.1K
- Earning Date
- REKR 05-14-2025
- RAPT 05-08-2025
- Dividend Yield
- REKR N/A
- RAPT N/A
- EPS Growth
- REKR N/A
- RAPT N/A
- EPS
- REKR N/A
- RAPT N/A
- Revenue
- REKR $46,028,000.00
- RAPT N/A
- Revenue This Year
- REKR $14.53
- RAPT N/A
- Revenue Next Year
- REKR $17.91
- RAPT N/A
- P/E Ratio
- REKR N/A
- RAPT N/A
- Revenue Growth
- REKR 31.76
- RAPT N/A
- 52 Week Low
- REKR $0.62
- RAPT $0.75
- 52 Week High
- REKR $2.67
- RAPT $8.58
- Technical
- Relative Strength Index (RSI)
- REKR 55.80
- RAPT 37.27
- Support Level
- REKR $0.86
- RAPT $0.75
- Resistance Level
- REKR $1.05
- RAPT $0.85
- Average True Range (ATR)
- REKR 0.07
- RAPT 0.08
- MACD
- REKR 0.02
- RAPT 0.00
- Stochastic Oscillator
- REKR 79.17
- RAPT 20.23
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.